Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints
In recent years, the role of cancer immunotherapy has become increasingly important compared to traditional cancer treatments, including surgery, chemotherapy and radiotherapy. Of note, the clinical successes of immune checkpoint blockade, such as PD-1 and CTLA-4, represent a landmark event in cance...
Main Authors: | Tao Shi, Yanyu Ma, Lingfeng Yu, Jiaxuan Jiang, Sunan Shen, Yayi Hou, Tingting Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/5/1389 |
Similar Items
-
Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
by: Chang-Myung Oh, et al.
Published: (2020-10-01) -
Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies
by: I-Tsu Chyuan, et al.
Published: (2021-03-01) -
Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma
by: Tietze Stefanie, et al.
Published: (2021-04-01) -
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
by: Xiaolei Li, et al.
Published: (2018-02-01) -
The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients
by: Katarzyna Tomela, et al.
Published: (2020-09-01)